U.S. Markets close in 4 hrs 55 mins

Rite Aid Corporation (RAD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
7.30+0.32 (+4.51%)
As of 11:05AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.98
Bid7.34 x 800
Ask7.35 x 1000
Day's Range7.13 - 7.49
52 Week Range4.68 - 19.22
Avg. Volume4,347,508
Market Cap406.852M
Beta (5Y Monthly)1.00
PE Ratio (TTM)N/A
EPS (TTM)-3.12
Earnings DateApr 13, 2022 - Apr 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 14, 1999
1y Target Est3.00
  • Motley Fool

    Zoom Video Communications: Bull vs. Bear

    Why Rite Aid's (NYSE: RAD) stock pop and raised guidance still aren't enough to get him interested in buying shares. Additionally, with shares down nearly 70% over the past year, is Zoom Video Communications (NASDAQ: ZM) a screaming buy or past its prime? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.

  • Yahoo Finance Video

    Walgreens earnings top estimates, sales drop 4.2%

    Yahoo Finance Live anchors discuss third-quarter earnings for Walgreens.

  • Business Wire

    Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members

    PHILADELPHIA, June 30, 2022--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.